tirzepatide pulled from shelves Drug of the Day: (Mounjaro), What it is, how it works, who it’s for, and the biggest misconceptions I see as a pharmacist. If you’re on Mounjaro or thinking about it, this is for you. * 🚨 BREAKING: Lilly Shutting Down

Acta Materia Medica

A healthcare professional would need to carefully adjust the doses, and this could be risky, especially for people with certain health problems like a history of seizures

Hims & Hers said Monday that it will likely stop offering compounded copies of commercially available semaglutide on its platform after its first quarter, although some patients may still be able to access personalized doses if clinically applicable

For example, a study published in the New England Journal of Medicine found that participants lost an average of 15% of their body weight after 68 weeks of semaglutide treatment